Celltrion to buy back 100 bln won in shares to boost shareholder value
--------------------------------------------------------------------
Source: South Korea
Published: 2026-04-22 16:07 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: South Korea
--------------------------------------------------------------------
Snippet:
SEOUL, April 22 (Yonhap) -- Celltrion Inc., a leading South Korean biopharmaceutical company, said Wednesday it plans to repurchase 100 billion won (US$68 million) worth of its own shares as part of its efforts to enhance shareholder value.
--------------------------------------------------------------------